STERON CAPSULES

Mechanism of action

Cyanocobalamin serves as a cofactor for methionine synthase and L-methylmalonyl-CoA mutase enzymes. Methionine synthase is essential for the synthesis of purines and pyrimidines that form DNA. L-methylmalonyl-CoA mutase is involved in the degradation of propionate, crucial for fat and protein metabolism. The lack of vitamin B12 results in the accumulation of methylmalonyl CoA, contributing to neurological manifestations. Additionally, it is vital for the synthesis of methionine from homocysteine, and its deficiency can lead to functional folate deficiency, which impacts red blood cell formation.

Pharmacodynamics

Cyanocobalamin corrects vitamin B12 deficiency and alleviates symptoms and laboratory abnormalities associated with pernicious anemia, such as megaloblastic indices, gastrointestinal lesions, and neurological damage. It is essential for growth, cell reproduction, hematopoiesis, nucleoprotein, and myelin synthesis. The drug significantly impacts fat and carbohydrate metabolism, as well as protein synthesis. Rapidly dividing cells, such as those in the bone marrow, have a high demand for vitamin B12. Parenteral administration of cyanocobalamin can quickly reverse the anemia and gastrointestinal symptoms of vitamin B12 deficiency, while also preventing the progression of related neurological damage.

Pharmacokinetics

Cyanocobalamin is absorbed in the intestine, primarily in the ileum, via specific transport mechanisms that may be impaired in individuals with intrinsic factor deficiency (as seen in pernicious anemia). Once absorbed, it is widely distributed in body tissues, with significant concentrations found in the liver, kidneys, and heart. The vitamin is stored in the liver, where it can be released into circulation as needed. Cyanocobalamin undergoes conversion to its active forms, methylcobalamin and adenosylcobalamin, which are utilized in various metabolic processes. The elimination half-life is variable, but it is generally excreted via urine as metabolites

Adverse effects

• Abdominal distension
• Decreased appetite
• Flatulence
• Nausea

Interactions

• Folic acid may interact with cyanocobalamin, especially in cases of megaloblastic anemia caused by folate deficiency.

Precautions

• Should not be given alone for pernicious anemia.
• Use caution in patients with Leber's disease, as it may worsen optic atrophy.

Pregnancy

Cyanocobalamin is essential during pregnancy as it helps prevent neural tube defects. It is advised that females of childbearing potential take 5 mg of folic acid daily before conception and throughout pregnancy.

Breast-feeding

Cyanocobalamin is generally considered safe during breastfeeding, but it is advised to monitor the infant for any adverse effects.

Storage

Store in a cool, dry place, away from direct sunlight. Protect from moisture.

Formulations

• Tablet: 1000 micrograms
• Tablet: 500 micrograms
• Tablet: 100 micrograms
• Oral solution: 50 micrograms per ml
• Solution for injection: 1000 micrograms per ml

Indications

• Preservative in food products
• Treatment of metabolic disorders, particularly urea cycle disorders
• Antimicrobial agent in pharmaceutical formulations

Dosage

Children: Refer to the BNF for Children for appropriate dosing information.

Adults: Refer to specific clinical guidelines and the BNF for appropriate dosing information.

Mechanism of action

Benzoic acid exerts its effects by converting to benzoyl-CoA in the body, which then participates in various metabolic pathways. It acts primarily by inhibiting the growth of fungi and bacteria through disruption of their cell membranes, thus preventing their reproduction and survival. This mechanism is particularly effective against certain yeasts and molds.

Pharmacodynamics

The pharmacodynamic properties of benzoic acid involve its ability to lower the pH of the environment in which it is present, leading to a decreased availability of protons for microbial growth. This acidic environment disrupts the cellular processes of microbes, leading to cell death. Additionally, it may interact with energy metabolism pathways within microbial cells, further contributing to its antimicrobial effects.

Pharmacokinetics

Benzoic acid is well absorbed from the gastrointestinal tract following oral administration. It is metabolized primarily in the liver to hippuric acid, which is then excreted in urine. The elimination half-life of benzoic acid is typically short, ranging from 0.5 to 1 hour, depending on individual metabolic variations. Factors such as renal function can significantly influence the pharmacokinetics of benzoic acid, as impaired kidney function may prolong its half-life.

Pregnancy

The safety of acidbp during pregnancy has not been established. It is important to weigh the potential benefits against any potential risks.

Breast-feeding

It is not known whether acidbp is excreted in human milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Dosage

Children: Refer to specific drug guidelines or BNF for Children for accurate dosing information.

Adults: Refer to specific drug guidelines or BNF for accurate dosing information.

Mechanism of action

The mechanism of action of complex drugs can vary widely depending on their composition. Generally, these agents may act by modulating receptor activity, inhibiting enzyme pathways, or altering cellular signaling pathways. For instance, they may function as agonists or antagonists at specific receptors, influencing physiological responses such as neurotransmission or inflammation.

Pharmacodynamics

The pharmacodynamics of complex drugs involves understanding how they affect the body over time, including their potency, efficacy, and duration of action. These drugs may exhibit dose-dependent effects, where higher doses lead to increased therapeutic actions or side effects. Additionally, the interactions between the components of a complex formulation can result in synergistic or antagonistic effects, impacting the overall therapeutic outcome.

Pharmacokinetics

Pharmacokinetics of complex drugs encompasses the absorption, distribution, metabolism, and excretion (ADME) of the drug components. Absorption can be influenced by the formulation, while distribution may vary based on the lipophilicity and protein binding of each component. Metabolism often occurs in the liver, with various enzymes involved, and excretion typically takes place via renal or biliary pathways. The half-life of complex drugs can vary significantly based on their individual components.

Pregnancy

Consult healthcare provider. Risk-benefit assessment is essential before use.

Breast-feeding

Consult healthcare provider. Monitor for potential effects on the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Mechanism of action

Folic acid is biochemically inactive until it is converted into active forms, primarily tetrahydrofolic acid and methyltetrahydrofolate, by the enzyme dihydrofolate reductase (DHFR). These active forms are essential for maintaining normal erythropoiesis, synthesizing nucleic acids, interconverting amino acids, and generating formate. They participate in critical one-carbon transfer reactions necessary for DNA synthesis and methylation processes. Folic acid, in conjunction with vitamin B12, helps normalize elevated homocysteine levels by facilitating its remethylation to methionine, a process that is crucial for various metabolic pathways.

Pharmacodynamics

Folic acid is an essential cofactor for enzymes involved in nucleic acid synthesis and amino acid metabolism. It is particularly significant in preventing megaloblastic anemia, which arises from impaired DNA synthesis due to folate deficiency. The synthesis of thymidylate, necessary for DNA formation, is directly influenced by folate availability. Folic acid's role is especially crucial during periods of rapid cellular division, and it has protective effects against certain cancer developments. As humans cannot synthesize folic acid endogenously, adequate dietary intake is essential for maintaining normal physiological functions.

Pharmacokinetics

Folic acid is absorbed in the small intestine and is then converted into its active forms within the body. The bioavailability of folic acid is influenced by factors such as food composition and the presence of certain gastrointestinal conditions. Once absorbed, it is transported in the bloodstream, mainly as 5-methyltetrahydrofolate. The distribution of folate occurs within various tissues, with significant

Adverse effects

• Allergic reactions
• Gastrointestinal disturbances
• Skin rash
• Altered sleep patterns

Interactions

• Anticonvulsants may reduce the effectiveness of folic acid
• Methotrexate may interfere with folic acid metabolism
• Trimethoprim-sulfamethoxazole can enhance the effects of folic acid deficiency

Precautions

• Monitor for signs of anemia in patients with malabsorption syndromes
• Use cautiously in patients with a history of hypersensitivity to folic acid
• Assess for vitamin B12 deficiency before initiating treatment, as folic acid can mask symptoms

Pregnancy

Folic acid is essential during pregnancy to prevent neural tube defects and support fetal development. Supplementation is recommended before conception and during the first trimester.

Breast-feeding

Folic acid passes into breast milk, and adequate maternal intake is important to ensure sufficient levels for the nursing infant.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Tablets
• Oral solutions
• Injectable forms

Dosage

Children: Refer to specific guidelines for pediatric dosing; consult the BNF for Children for accurate dosage information.

Adults: Refer to specific guidelines for use; dosage may vary based on the context of use.

Mechanism of action

Hydroxide ions act primarily as bases, neutralizing acids to form water and salts. They participate in various biochemical pathways, including selenium metabolism and the degradation of reactive oxygen species. Hydroxide can influence enzyme activity and stability by altering the pH of the environment, thereby affecting metabolic reactions.

Pharmacodynamics

Hydroxide ions can impact biological processes by changing the local pH, which influences enzyme activity, ion transport, and the solubility of other compounds. Their ability to neutralize acids can help regulate physiological pH, contributing to homeostasis in living organisms.

Pharmacokinetics

As an inorganic ion, hydroxide does not undergo traditional pharmacokinetic processes like absorption, distribution, metabolism, or excretion. Instead, it is rapidly equilibrated in biological fluids and participates in acid-base reactions, having immediate effects on the local environment.

Pregnancy

There is limited information regarding the use of hydroxide during pregnancy. Consult a healthcare professional for advice.

Breast-feeding

Limited data is available on the excretion of hydroxide in breast milk. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Nutritional supplementation
• Management of blood glucose levels in diabetes
• Energy source for athletes or individuals with increased energy demands
• Support for gut health as a prebiotic

Dosage

Children: Refer to specific product guidelines for dosing, as it may vary based on formulation and indication.

Adults: Refer to specific product guidelines for dosing, as it may vary based on formulation and indication.

Mechanism of action

Polymaltose is metabolized into glucose, which serves as a source of energy for the body. It is characterized by its slow digestion and absorption, which helps maintain steady blood glucose levels. The slow-release characteristic is attributed to its polysaccharide structure, which requires enzymatic breakdown in the gastrointestinal tract before absorption occurs.

Pharmacodynamics

The pharmacodynamics of polymaltose involve its role in providing a sustained release of glucose into the bloodstream, which can prevent spikes in blood sugar levels. This gradual release is particularly advantageous in managing energy levels for individuals with diabetes or those needing controlled carbohydrate intake. Additionally, polymaltose may exhibit prebiotic effects, enhancing the growth of beneficial intestinal microbiota, thus contributing to improved gastrointestinal health.

Pharmacokinetics

Polymaltose is not directly absorbed in the gastrointestinal tract due to its complex structure. Instead, it undergoes enzymatic hydrolysis primarily in the small intestine, where it is broken down into glucose units. The absorption of these glucose units occurs through the intestinal mucosa into the bloodstream. The rate of absorption is slower compared to simple sugars, resulting in a gradual increase in blood glucose levels. The elimination of glucose from the bloodstream is mediated by insulin, which facilitates its uptake by tissues for energy production.

Adverse effects

• Gastrointestinal discomfort
• Nausea
• Diarrhea
• Allergic reactions (rare)

Precautions

• Use with caution in patients with diabetes mellitus due to potential carbohydrate content
• Monitor for gastrointestinal side effects, especially in patients with pre-existing gastrointestinal disorders

Pregnancy

Polymaltose is generally considered safe during pregnancy, but medical advice should be sought before use.

Breast-feeding

Polymaltose is likely safe during breastfeeding, but it is advisable to consult with a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral syrup
• Oral solution
• Granules

Indications

• Detoxification support
• Support in metabolic processes
• Potential adjunct in managing connective tissue disorders

Dosage

Children: Refer to individual clinical guidelines for specific dosing recommendations, as sulphate does not have a standardized therapeutic dose.

Adults: Refer to individual clinical guidelines for specific dosing recommendations, as sulphate does not have a standardized therapeutic dose.

Mechanism of action

Sulphate acts as a cofactor in various enzymatic reactions. It is essential for the sulfation process, whereby sulfate groups are added to organic compounds. This process helps in the detoxification of drugs and the metabolism of hormones. Sulphate also contributes to the synthesis of glycosaminoglycans, which are vital for maintaining cartilage and other connective tissues.

Pharmacodynamics

Sulphate has a role in cellular signaling and the modulation of various metabolic pathways. It can influence the activity of several enzymes involved in the metabolism of xenobiotics and endogenous compounds. Furthermore, sulphate may have antioxidant properties and can help to protect cells from oxidative stress.

Pharmacokinetics

Sulphate is absorbed in the gastrointestinal tract and is distributed throughout the body. It is metabolized in the liver, where it undergoes sulfation reactions. The elimination of sulphate occurs primarily through renal excretion, with a significant amount being excreted in urine. The half-life of sulphate in the body can vary depending on individual metabolic rates and the presence of other compounds.

Pregnancy

Sulphat is generally not recommended during pregnancy unless the benefits outweigh the risks. It is important to consult a healthcare professional for specific guidance.

Breast-feeding

It is not known whether sulphat is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Mechanism of action

Vitamin B12 serves as a cofactor for _methionine synthase_ and _L-methylmalonyl-CoA mutase_ enzymes. Methionine synthase is essential for the synthesis of purines and pyrimidines that form DNA. L-methylmalonyl-CoA mutase converts L-methylmalonyl-CoA to _succinyl-CoA_ in the degradation of propionate, an important reaction required for both fat and protein metabolism. It is a lack of vitamin B12 cofactor in the above reaction and the resulting accumulation of methylmalonyl CoA that is believed to be responsible for the neurological manifestations of B12 deficiency. Succinyl-CoA is also necessary for the synthesis of hemoglobin. In tissues, vitamin B12 is required for the synthesis of _methionine_ from homocysteine. Methionine is required for the formation of S-adenosylmethionine, a methyl donor for nearly 100 substrates, comprised of DNA, RNA, hormones, proteins, as well as lipids. Without vitamin B12, tetrahydrofolate cannot be regenerated from 5-methyltetrahydrofolate, and this can lead to functional folate deficiency,. This reaction is dependent on methylcobalamin (vitamin B12) as a co-factor and is also dependent on folate, in which the methyl group of methyltetrahydrofolate is transferred to homocysteine to form _methionine_ and _tetrahydrofolate_. Vitamin B12 incorporates into circulating folic acid into growing red blood cells; retaining the folate in these cells. A deficiency of vitamin B12 and the interruption of this reaction leads to the development of megaloblastic anemia.

Pharmacodynamics

**General effects** Cyanocobalamin corrects vitamin B12 deficiency and improves the symptoms and laboratory abnormalities associated with pernicious anemia (megaloblastic indices, gastrointestinal lesions, and neurologic damage). This drug aids in growth, cell reproduction, hematopoiesis, nucleoprotein, and myelin synthesis. It also plays an important role in fat metabolism, carbohydrate metabolism, as well as protein synthesis. Cells that undergo rapid division (for example, epithelial cells, bone marrow, and myeloid cells) have a high demand for vitamin B12. **Parenteral cyanocobalamin effects** The parenteral administration of vitamin B12 rapidly and completely reverses the megaloblastic anemia and gastrointestinal symptoms of vitamin B12 deficiency. Rapid parenteral administration of vitamin B12 in deficiency related neurological damage prevents the progression of this condition. **Nasal spray effects** In 24 vitamin B12 deficient patients who were already stabilized on intramuscular (IM) vitamin B12 therapy, single daily doses of intranasal cyanocobalamin for 8 weeks lead to serum vitamin B12 concentrations that were within the target therapeutic range (>200 ng/L).

Mechanism of action

Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase. Folic acid, after conversion to tetrahydrofolic acid, is necessary for normal erythropoiesis, synthesis of purine and thymidylates, metabolism of amino acids such as glycine and methionine, and the metabolism of histidine. The principal biochemical function of folates is the mediation of one-carbon transfer reactions. 5-Methyltetrahydrofolate donates a methyl group to homocystine, in the conversion of homocystine to L-methionine. ... 5,10-Methyltetrahydrofolate is regenerated from tetrahydrofolate via the enzyme serine hydroxymethyltransferase, a reaction, which in addition to producing 5,10-methyltetrahydrofolate, yields glycine. ... 5,10-methyltetrahydrofolate, supplies the one carbon group for the methylation of deoxyuridylic acid to form the DNA precursor thymidylic acid. This reaction is catalyzed by thymidylate synthase and the folate product of the reaction is dihydrofolate. Dihydrofolate is converted to tetrahydrofolate via the enzyme dihydrofolate reductase ...

Pharmacodynamics

Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.